Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
about
Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?Molecular concept in human oral cancerBiomarkers of head and neck cancer, tools or a gordian knot?Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinomaNanoparticle-based targeted therapeutics in head-and-neck cancerLessons learned from next-generation sequencing in head and neck cancerHER2 as a therapeutic target in head and neck squamous cell carcinomaUnderstanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.Oral premalignancy: the roles of early detection and chemopreventionMolecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.Toward the use of precision medicine for the treatment of head and neck squamous cell carcinomaIdentification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinomaSusceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolismEpidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expressionThe Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiationHigh level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patientsThe MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma.Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for TreatmentAdvances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.The impact of sphingosine kinase-1 in head and neck cancer.Clinical update on cancer: molecular oncology of head and neck cancerRETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.Nano-bio-chip sensor platform for examination of oral exfoliative cytologyGenes and oral cancerCombination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinomaTargeting the epidermal growth factor receptor for head and neck cancer chemopreventionIntegrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study.Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimuriumMolecular pathogenesis of oral squamous carcinoma.Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis.Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1.Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
P2860
Q26745755-066CD32F-1861-4A10-A1F9-F6174BE1F4EDQ26775850-1E7257B6-0CE6-428A-8BD0-F5BF0AFE2334Q26784289-048CE713-A4FC-49D7-803D-F23DFEDF06F0Q26991953-5C91D742-21AE-4394-8922-4D62248036DDQ26999699-5AA5BF73-823B-47C7-B313-348575F42D10Q27009209-45C21067-A09D-4194-B249-9ED05D6628ADQ27026178-4F64E151-FCB1-401B-B30C-56ECF458B44FQ27691330-B75B36B1-BCAB-4643-A1E5-3611CB7B57C7Q27693327-12C67B61-FCD3-438D-B00E-E6D61FA1EA2DQ27824854-53DB906A-492E-42D4-BFE8-E99691183E66Q27851592-63504A3A-8E63-46A1-BD8C-6ED2DCC43617Q28074691-42625490-C5D8-4508-A8AB-F38FDC7A1639Q28385950-1E321E0D-BAD4-4285-9FB9-8659C43E543AQ28484655-40CD2A44-64E1-4C46-A6D9-D7E1C1609BF8Q28485910-A4E36711-0750-486C-A6E6-1BB31B5D53E3Q28507071-8C3B0B56-E4B7-4F35-9442-795CE72D21B6Q28658539-C28D209E-583E-4285-AE14-126054F3A1AFQ30494514-E84E42C8-4A9C-4E61-834C-9FA164B0E8EFQ30955321-6D656068-A954-43B9-9859-E78DE05AD33AQ33591405-C1E02AFE-07DE-4BD2-9E91-10DA648509F6Q33607965-82FCE566-E835-4FAB-83A3-7E6C9F423BCCQ33610394-2FF54955-6AE6-4276-B1AF-1AF695EB7239Q33649748-449DA471-9FAE-4529-82F2-9779EED4623BQ33695197-57350E8C-2FDE-46F8-A984-49D580C5DC65Q33723572-EBF44AA2-77E9-4D00-A774-C652AD850ED4Q33767100-C7D7D8FA-6736-433A-BEF4-DBC5C0F5C6FFQ33785690-98552CA8-6EFF-4ACB-AABC-BC615AB396C2Q33785869-E3CF59C9-F039-4270-9593-31BF10858B66Q33875560-08DBDEAF-3475-4441-9F93-823B99633D0CQ33875694-0F950A0A-1761-408E-B79E-2E1F59FCB605Q33896397-4CBED108-31A5-47F6-8637-7679A42A7C6BQ33914020-428DC46C-DB21-4811-8D45-BBC93130BAD4Q33918555-186C05B9-3531-41B0-8A79-65EEE7928C2AQ33976619-D57CF697-9DB6-410B-8B79-3CABE993E33DQ34012333-4A42CA86-13BE-4A91-94A1-EEE57F7E4DD0Q34049613-C36B319B-58CE-4226-B5F2-F09640CABD9AQ34098308-55731861-EC28-4C44-8715-2CD46CA82EFFQ34129430-377BEB40-986B-4495-A3DE-EB7BE056FB28Q34135975-55D01D27-A677-44D1-8554-4C9BFBEE3A32Q34159125-A7FD8866-80D9-4F52-AA6D-E2CB3DB400DE
P2860
Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Elevated levels of transformin ...... nesis in head and neck cancer.
@en
Elevated levels of transformin ...... nesis in head and neck cancer.
@nl
type
label
Elevated levels of transformin ...... nesis in head and neck cancer.
@en
Elevated levels of transformin ...... nesis in head and neck cancer.
@nl
prefLabel
Elevated levels of transformin ...... nesis in head and neck cancer.
@en
Elevated levels of transformin ...... nesis in head and neck cancer.
@nl
P1433
P1476
Elevated levels of transformin ...... enesis in head and neck cancer
@en
P2093
Grandis JR
Tweardy DJ
P304
P407
P577
1993-08-01T00:00:00Z